The PE Ratio as of October 2024 (TTM) for Acasti Pharma Inc. (ACST) is -2.36

According to Acasti Pharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.36. This represents a change of -10.09% compared to the average of -2.62 of the last 4 quarters.

Acasti Pharma Inc. (ACST) Historical PE Ratio (quarterly & annually)

How has ACST PE Ratio performed in the past?

The mean historical PE Ratio of Acasti Pharma Inc. over the last ten years is -9.15. The current -2.36 PE Ratio has changed 2.48% with respect to the historical average. Over the past ten years (40 quarters), ACST's PE Ratio was at its highest in in the May 2014 quarter at 19.74. The PE Ratio was at its lowest in in the May 2015 quarter at -14.15.

Acasti Pharma Inc. (ACST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Acasti Pharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acasti Pharma Inc. (ACST) Average PE Ratio

How has ACST PE Ratio performed in the past?

The current PE Ratio of Acasti Pharma Inc. (ACST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Acasti Pharma Inc. (ACST) PE Ratio vs. Peers

How is ACST’s PE Ratio compared to its peers?

Acasti Pharma Inc.’s PE Ratio is less than Tonix Pharmaceuticals Holding Corp. (-0.00), less than Jaguar Health, Inc. (-0.07), less than Diffusion Pharmaceuticals Inc. (-0.00), less than iBio, Inc. (-0.40), less than Aridis Pharmaceuticals, Inc. (0.00), less than Akari Therapeutics, Plc (-1.11), less than Aditxt, Inc. (-0.02), less than ABVC BioPharma, Inc. (-0.63), less than Pulmatrix, Inc. (-0.70), less than Onconova Therapeutics, Inc. (-1.15), less than Catalyst Biosciences, Inc. (-0.44), less than Bio-Path Holdings, Inc. (-0.14), less than Moleculin Biotech, Inc. (-0.25), less than Advaxis, Inc. (-0.00), less than GeoVax Labs, Inc. (-0.17), greater than Ocugen, Inc. (-4.88),

Build a custom stock screener for Acasti Pharma Inc. (ACST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acasti Pharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acasti Pharma Inc. (ACST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acasti Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.